1. Home
  2. ADXN vs OGEN Comparison

ADXN vs OGEN Comparison

Compare ADXN & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • OGEN
  • Stock Information
  • Founded
  • ADXN 2002
  • OGEN 1996
  • Country
  • ADXN Switzerland
  • OGEN United States
  • Employees
  • ADXN N/A
  • OGEN N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADXN Health Care
  • OGEN Health Care
  • Exchange
  • ADXN Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • ADXN 8.9M
  • OGEN 9.8M
  • IPO Year
  • ADXN N/A
  • OGEN N/A
  • Fundamental
  • Price
  • ADXN $8.32
  • OGEN $1.12
  • Analyst Decision
  • ADXN
  • OGEN
  • Analyst Count
  • ADXN 0
  • OGEN 0
  • Target Price
  • ADXN N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • ADXN 3.0K
  • OGEN 114.3K
  • Earning Date
  • ADXN 08-08-2024
  • OGEN 08-12-2024
  • Dividend Yield
  • ADXN N/A
  • OGEN N/A
  • EPS Growth
  • ADXN N/A
  • OGEN N/A
  • EPS
  • ADXN N/A
  • OGEN N/A
  • Revenue
  • ADXN $1,568,105.00
  • OGEN $20,629.00
  • Revenue This Year
  • ADXN N/A
  • OGEN N/A
  • Revenue Next Year
  • ADXN N/A
  • OGEN N/A
  • P/E Ratio
  • ADXN N/A
  • OGEN N/A
  • Revenue Growth
  • ADXN N/A
  • OGEN N/A
  • 52 Week Low
  • ADXN $5.00
  • OGEN $0.97
  • 52 Week High
  • ADXN $27.90
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 47.55
  • OGEN 40.03
  • Support Level
  • ADXN $8.10
  • OGEN $1.00
  • Resistance Level
  • ADXN $8.67
  • OGEN $1.24
  • Average True Range (ATR)
  • ADXN 0.18
  • OGEN 0.08
  • MACD
  • ADXN 0.14
  • OGEN 0.02
  • Stochastic Oscillator
  • ADXN 72.16
  • OGEN 32.08

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: